Cabio is a biotechnology company founded in 2004, based in Wuhan, China, and listed in Shanghai Stock Exchange (688089.SH). We supply LCPUFAs (algal DHA and fungal ARA) to the global market with state-of-the-art smart plant and robust supply chain for infant formula, dietary supplement, food for special medical purpose and animal nutrition customers.
We have established one of the world largest LCPUFA manufacturing plants with full set of capabilities from bio-fermentation, non-solvent extraction, refining, winterization, to microencapsulation. We can offer the market with multiple product forms for various applications.
Algal DHA: 40% oil (infant grade), 50% winterized oil, 10% powder, 20% powder, and 10% non-protein powder
Arachidonic Acid (ARA): 40% oil (infant grade), 10% powder, 20% powder, and 10% non-protein powder
Company Category
- Crude Oil Supplier
- Refiner
- Brand
- Contract Manufacturer/Encapsulator
- Value Add Manufacturer (Powders, Emulsions, etc.)
Raw Material Source
-
Algae
- Algal DHA Oil
Omega-3 Chemical Form
- Triglyceride
Product Form
- Emulsion
- Liquid/oil (Refined oil, Crude Oil)
- Powder
Finished Product Category
- Clinical Nutrition/Medical Foods
- Dietary Supplement
- Fortified Food/Beverage
- Infant Formula
- Pet Food & Supplements